Spruce Biosciences (NASDAQ:SPRB – Get Free Report)‘s stock had its “market outperform” rating reiterated by stock analysts at Citizens Jmp in a research note issued on Thursday, Benzinga reports. They presently have a $144.00 price objective on the stock. Citizens Jmp’s target price would suggest a potential upside of 191.38% from the company’s previous close. […]

Lennar (NYSE:LEN – Get Free Report)‘s stock had its “market perform” rating restated by investment analysts at Citizens Jmp in a research report issued on Thursday, Benzinga reports. Several other research firms have also recently commented on LEN. Bank of America cut their price target on Lennar from $77.00 to $70.00 and set an “underperform” […]

Affirm (NASDAQ:AFRM – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by Citizens Jmp in a note issued to investors on Wednesday, Benzinga reports. They currently have a $85.00 price objective on the stock. Citizens Jmp’s price objective points to a potential upside of 17.91% from the stock’s previous close. A number of […]